Trump administration announces 15 new drugs for Medicare price negotiation program

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the federal government to haggle directly with drug manufacturers.

Humana, UnitedHealth plunge 20% after Trump administration proposes keeping Medicare Advantage rates flat

Shares of large Medicare plan providers Humana, CVS Health and UnitedHealth Group plunged in extended trading.
AARP

Medicare Names 15 New Drugs for Third Round of Cost-Cutting Price Negotiations

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into effect until 2028.

Botox, Trulicity among 15 drugs on new Medicare negotiations list

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug Price Negotiation Program, including high-cost medications like Botox

S&P 500 marks closing record as corporate earnings roll in; Medicare rates hit insurers

The S&P 500 notched a record closing high and its fifth straight day of gains ​on Tuesday with a mixed reception to the latest earnings reports and a steep selloff in health insurers countering optimism ahead ‌of megacap reports.

Medicare will negotiate the price of Botox and 14 other drugs this year

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

Higher Medicare premiums will eat up more than 25% of Social Security’s COLA

Too much of our national and personal resources are being used to pay for healthcare.